Equity Analysis /
United States of America

US : Intellia Therapeutics, Inc. - NTLA | 3Q21 Update: Key TTR Data Update 1Q22

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    4 November 2021
    Published by